Intensive Preventative Dental Program Pilot Study

Inclusion Criteria

• •Aged 18 years and older
• •Willing and able to provide signed and dated consent form
• •Presence of at least 4 natural erupted teeth remaining in the mouth after completion of pre-RT dental management
• •Diagnosed with head and neck squamous cell carcinoma (SCC) or a salivary gland cancer (SGC), and intends to receive external beam radiation therapy (RT) with curative intent (tumor eradication), with or without concomitant chemotherapy;
• •OR
• •Diagnosed with a non-SCC, non-SGC malignancy of the head and neck region, and intends to receive RT, with or without concomitant chemotherapy. The participant must be expected to receive at least 4500 cGy to one of the following sites:
• •1. base of tongue
• •2. buccal/labial mucosa
• •3. epiglottis
• •4. floor of mouth
• •5. gingiva/alveolar ridge
• •6. hard palate
• •7. hypopharynx
• •8. larynx
• •9. lip
• •10. mandible
• •11. maxilla
• •12. maxillary sinus
• •13. nasal cavity
• •14. nasopharynx
• •15. neck
• •16. oral cavity
• •17. oral tongue
• •18. oropharynx
• •19. paranasal sinus/orbit
• •20. parotid gland
• •21. pharynx
• •22. retromolar trigone
• •23. soft palate
• •24. sublingual gland
• •25. submandibular gland
• •26. tonsil;
• •Willing to comply with all study procedures
• •Willing to participate for the duration of the study
• •RT follow-up planned for one of the selected AH Oncology Specialist Follow-up Sites.